Richmond Pharmacology is proud to announce that it will be hosting the AHPPI Winter Meeting early next month.

Posted:
7
December 2009

Richmond Pharmacology is proud to announce that it will be hosting the AHPPI Winter Meeting early next month.The AHPPI is an informal cross-industry discussion group whose purpose is to address issues facing those involved in early phase drug development and to educate members through directed symposia at each of its 2 meetings per year.The Association has been in existence for over nearly 2 decades and has forged links with both other scientific societies with similar interests and with professional bodies such as the ABPI and ICR.   For several years, the association has been organising joint biannual meetings with the clinical section of the British Pharmacological Society , all of which have been very successful and will continue in the future.This year s AHPPI Annual Winter meeting will be hosted at St George s Hospital, University of London, Tooting and will take place on 4th February 2010. We kindly invite all members of the AHPPI as well as those who are not members and keen to attend, to join us on the day.The meeting has recently been awarded 3 CPD points by the Faculty of Pharmaceutical Physicians.The topic of discussion will be �Current Advances in the Development of Vaccines and Biopharmaceuticals: A Challenge not be Sneezed at?� and there is an exciting list of key speakers already lined up for the day, namely;�    Professor David Lewis, St George�s Vaccine Institute�    Dr Afshan Ahmad, Vaccine Research International�    Dr Simon Beddows, Health Protection Agency�    Dr Azharul Mannan, Sanofi Pasteur MSD�    Professor Geoff Hale, BioAnaLab�    Professor John Oxford, Retroscreen Virology Ltd.�    Andrew Nolan, QuintilesFor further details for what�s in store for the day, please click here to view the meeting agenda.If you would like to register for this meeting; please complete our online registration form.If you would like to request more information, please email us at info@richmondpharmacology.com or complete our online enquiry form.Registrations for AHPPI members: �20.00Registrations for non-members: �50.00

Richmond Pharmacology is proud to announce that it will be hosting the AHPPI Winter Meeting early next year.

Latest news

Upcoming Event

ACCP 2020, Translating Clinical Pharmacology Research into Patient-centered Care

21 - 23 September 2020
Dr. Jorg Taubel will be presenting posters that explore the subjects of cardiac health and diabetes.
View event

Richmond Pharmacology is delighted to confirm partnership with Intellia Therapeutics

October 20, 2020
Phase I study of Intellia Therapeutic’s NTLA-2001 for the treatment of hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN)
Read more

Richmond Pharmacology supports ReViral with the development of Sisunatovir

September 9, 2020
ReViral has confirmed the FDA has granted Fast Track designation to Sisunatovir.
Read more

Richmond Pharmacology helps UK patients gain early access to ultra-rare disease drug Lumasiran

August 17, 2020
Richmond Pharmacology early phase drug development update.
Read more